Analytical and Bioanalytical Solutions - Empowering Drug Development and Manufacturing
Houston, TX
Joined July 2011
- Tweets161
- Following10
- Followers39
- Likes0
The FDA has released three new draft guidances designed to accelerate and strengthen the development of cell and gene therapies, marking a significant step forward for the field. avancebio.com/fda-issues-thr…
Avance Biosciences offers CGMP- and GLP-compliant assay development, validation, and sample testing for biopharma. Visit our booth #2934 to explore how we support drug development and manufacturing with precision and expertise. avancebio.com/aaps-pharmsci-…
Avance Biosciences’ NGS Center of Excellence delivers comprehensive sequencing solutions, including short-read, long-read, and advanced single-cell platforms. Our regulatory-compliant workflows support biologics, gene, and cell therapy programs with... avancebio.com/avance-bioscie…
Avance Biosciences is heading to the BioProcessing Summit next week! Booth #516
avancebio.com/avance-bioscie…
To support IND-enabling studies, a biotech company needed precise measurement of in vivo gene-editing efficiency in preclinical rat tissues. Avance Biosciences delivered a fully validated NGS amplicon sequencing assay capable of detecting edits as low... avancebio.com/case-study-qua…
When a gene therapy company needed to verify plasmid identity, purity, and integrity for an IND submission, Avance Biosciences delivered a validated NGS-based solution. The assay enabled low-level variant detection and trace contaminant analysis... avancebio.com/ensuring-plasm…
Potency assays are critical for demonstrating the safety and efficacy of biologics, but developing them can be complex, especially for cell and gene therapies. Download our latest technote: Successful Development of Cell-based Potency Assays avancebio.com/literature-dow…
Our new blog series explore how cutting-edge NGS technologies are being applied to solve real-world challenges in biopharmaceutical development. Follow along for insights into assay strategies, platform selection, and the measurable impact of our... avancebio.com/new-blog-serie…
Avance Biosciences™ be presenting two posters as part of the Next-Gen Analytical Methods program: Genome-wide Mapping of CRISPR-Cas Off-Target Cleavage Sites via GUIDE-Seq & Digitally Secure Sequencing: Implementing Part 11-Ready NGS Data Security in... avancebio.com/avance-bioscie…
We’ve expanded our bioanalytical capabilities with powerful LC-MS/MS services to provide highly sensitive and accurate analytical solutions for drug development, biomarker discovery, and biologics characterization.
avancebio.com/avance-bioscie…
We’re excited to share that Avance Biosciences™ will be exhibiting at the BioProcessing Summit 2025, taking place August 18–21 in Boston, MA. (Booth No. 516) avancebio.com/join-avance-at…
Avance Biosciences is proud to announce the launch of its Next-Generation Sequencing (NGS) Center of Excellence, a purpose-built facility designed to unify and enhance the company’s sequencing capabilities across all phases of drug development. avancebio.com/avance-bioscie…
Avance is growing to better support biopharmaceutical drug development and manufacturing. We are continuing to add new technologies and platforms to support our clients’ needs. avancebio.com/avance-is-grow…